BIBW2992, an irreversible EGFR/HER2 inhibitor highly effective in preclinical lung cancer models.

Saved in:
Bibliographic Details
Title: BIBW2992, an irreversible EGFR/HER2 inhibitor highly effective in preclinical lung cancer models.
Authors: Li, D.1,2, Ambrogio, L.1,3, Shimamura, T.1,4, Kubo, S.5, Takahashi, M.5, Chirieac, L. R.6, Padera, R. F.6, Shapiro, G. I.1,4, Baum, A.7, Himmelsbach, F.8, Rettig, W. J.7, Meyerson, M.1,3,4, Solca, F.7 flavio.solca@vie.boehringer-ingelheim.com, Greulich, H.1,3,4, Wong, K.-K.1,4
Source: Oncogene. 8/7/2008, Vol. 27 Issue 34, p4702-4711. 10p. 1 Chart, 4 Graphs.
Database: Academic Search Ultimate
Description
ISSN:09509232
DOI:10.1038/onc.2008.109